- Available
NCT05238311: Pre-approval Single-patient Expanded Access for Elranatamab (PF-06863135)
NCT05238311: Pre-approval Single-patient Expanded Access for Elranatamab (PF-06863135)

Pre-approval Single-patient Expanded Access for Elranatamab (PF-06863135)
Provide pre-approval single-patient Expanded Access (Compassionate Use) of elranatamab for patients with relapsed/refractory multiple myeloma
Sponsor
Collaborator
In Expanded Access, treating physicians are the Sponsors
ClinicalTrials.gov Identifier: NCT05238311
NCT05238311: Pre-approval Single-patient Expanded Access for Elranatamab (PF-06863135)
First Posted : February 14, 2022
Click here for details on Clinicaltrials.gov